NAT10 and melanoma: used siRNA to inhibit NAT10 expression in human and mouse melanoma cells, resulting in S‐phase cell cycle arrest, with the mechanism involving NAT10 regulation of the p21/CDK2/cyclin D1 axis (Figure 4G).